REFERENCES
1. Cecconi, F.; Alvarez-Bolado, G.; Meyer, B. I.; Roth, K. A.; Gruss, P. Apaf1 (CED-4 Homolog) regulates programmed cell death in mammalian development. Cell 94, 727-37 (1998).
2. Fuchs, Y.; Steller, H. Programmed cell death in animal development and disease. Cell 147, 742-58 (2011).
3. Hartley, S. B.; Cooke, M. P.; Fulcher, D. A.; et al. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72, 325-35 (1993).
4. Galluzzi, L.; Guilbaud, E.; Schmidt, D.; Kroemer, G.; Marincola, F. M. Targeting immunogenic cell stress and death for cancer therapy. Nat. Rev. Drug Discov. 23, 445-60 (2024).
5. Galluzzi, L.; Kepp, O.; Zitvogel, L.; Tang, D.; Kroemer, G. Cancer cell death: Cell-autonomous and immunogenic dimensions. Cancer Cell 44, 281-305 (2026).
6. Yuan, J.; Ofengeim, D. A guide to cell death pathways. Nat. Rev. Mol. Cell Biol. 25, 379-95 (2024).
8. Dai, E. et al. A guideline on the molecular ecosystem regulating ferroptosis. Nat. Cell Biol. 26, 1447-57 (2024).
9. Dixon, S. J.; Olzmann, J. A. The cell biology of ferroptosis. Nat. Rev. Mol. Cell Biol. 25, 424-42 (2024).
10. Jiang, X.; Stockwell, B. R.; Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol. 22, 266-82 (2021).
11. Stockwell, B. R.; et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171, 273-85 (2017).
12. Chen, F.; Kang, R.; Tang, D.; Liu, J. Ferroptosis: principles and significance in health and disease. J. Hematol. Oncol. 17, 41 (2024).
13. Stockwell, B. R. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell 185, 2401-21 (2022).
14. Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060-72 (2012).
15. Liang, D.; Minikes, A. M.; Jiang, X. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol. Cell 82, 2215-27 (2022).
16. Sassano, M. L. et al. Endoplasmic reticulum-mitochondria contacts are prime hotspots of phospholipid peroxidation driving ferroptosis. Nat. Cell Biol. 27, 902-17 (2025).
17. Zou, Y. et al. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat. Chem. Biol. 16, 302-9 (2020).
18. Yang, W. S.; Kim, K. J.; Gaschler, M. M.; Patel, M.; Shchepinov, M. S.; Stockwell, B. R. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc. Natl. Acad. Sci. U S A. 113, E4966-75 (2016).
19. Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317-31 (2014).
20. Botta, D. et al. Modulating GSH synthesis using glutamate cysteine ligase transgenic and gene-targeted mice. Drug Metab. Rev. 40, 465-77 (2008).
21. Zhang, X. et al. Targeting PTDSS1 to modulate GSH synthesis triggers mitophagy and induces ferroptosis in esophageal squamous cell carcinoma cells. Cell Death Dis. 17, 538 (2026).
22. Jenke, R.; Heinrich, T.; Lordick, F.; Aigner, A. ERBB3 influences the ferroptosis pathway via modulation of lipid peroxidation and GSH synthesis in gastric cancer. Cell Death Discov. 11, 398 (2025).
23. Xu, Y.; Li, Y.; Li, J.; Chen, W. Ethyl carbamate triggers ferroptosis in liver through inhibiting GSH synthesis and suppressing Nrf2 activation. Redox Biol. 53, 102349 (2022).
24. Xiao, J. et al. Mitochondria-specific GPX4 inhibition enhances ferroptosis and antitumor immunity. J. Control. Release 383, 113841 (2025).
25. Akiyama, H. et al. Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia. Leukemia 38, 729-40 (2023).
26. Ingold, I. et al. Selenium utilization by GPX4 Is required to prevent hydroperoxide-induced ferroptosis. Cell 172, 409-22.e21 (2018).
27. Hu, Y. et al. Targeting PRDX6-dependent localization and function of GPX4 enhances ferroptosis-mediated tumor suppression. Mol. Cell 85, 4602-20.e9 (2025).
28. Ito, J. et al. PRDX6 dictates ferroptosis sensitivity by directing cellular selenium utilization. Mol. Cell 84, 4629-44.e9 (2024).
29. Fujita, H. et al. PRDX6 augments selenium utilization to limit iron toxicity and ferroptosis. Nat. Struct. Mol. Biol. 31, 1277-85 (2024).
30. Chen, Z. et al. PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance. Mol. Cell 84, 4645-59.e9 (2024).
31. Doll, S. et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575, 693-8 (2019).
32. Bersuker, K. et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575, 688-92 (2019).
33. Mishima, E. et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature 608, 778-83 (2022).
35. Soula, M. et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat. Chem. Biol. 16, 1351-60 (2020).
36. Kraft, V. A. N. et al. GTP Cyclohydrolase 1/Tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent. Sci. 6, 41-53 (2020).
37. Kolbrink, B. et al. Vitamin K1 inhibits ferroptosis and counteracts a detrimental effect of phenprocoumon in experimental acute kidney injury. Cell. Mol. Life Sci. 79, 387 (2022).
38. Wu, Z.; Khodade, V. S.; Chauvin, J. R.; Rodriguez, D.; Toscano, J. P.; Pratt, D. A. Hydropersulfides inhibit lipid peroxidation and protect cells from ferroptosis. J. Am. Chem. Soc. 144, 15825-37 (2022).
39. Barayeu, U. et al. Hydropersulfides inhibit lipid peroxidation and ferroptosis by scavenging radicals. Nat. Chem. Biol. 19, 28-37 (2022).
40. Chidley, C. et al. A CRISPRi/a screening platform to study cellular nutrient transport in diverse microenvironments. Nat. Cell Biol. 26, 825-38 (2024).
41. Zhang, D. D. Thirty years of NRF2: advances and therapeutic challenges. Nat. Rev. Drug Discov. 24, 421-44 (2025).
42. Emmanuel, N.; Li, H.; Chen, J.; Zhang, Y. FSP1, a novel KEAP1/NRF2 target gene regulating ferroptosis and radioresistance in lung cancers. Oncotarget 13, 1136-9 (2022).
43. Takahashi, N. et al. 3D Culture models with CRISPR screens reveal hyperactive NRF2 as a prerequisite for spheroid formation via regulation of proliferation and ferroptosis. Mol. Cell 80, 828-44.e6 (2020).
44. Sun, X. et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 63, 173-84 (2016).
45. Sun, X. et al. Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis. Hepatology 64, 488-500 (2016).
46. Anandhan, A. et al. NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8. Sci. Adv. 9, eade9585 (2023).
47. Xu, J. et al. Trifluoperazine induces ferroptosis in acute myeloid leukemia by suppressing the Nrf2/SLC7A11/GPX4 axis. Eur. J. Pharmacol. 1029, 179012 (2026).
48. Liu, C.; Dong, X.; Tang, B. Activation of the p62/Keap1/Nrf2 pathway protects against ferroptosis in cerebral ischemia-reperfusion injury. J. Integr. Neurosci. 25, 48011 (2026).
49. Tang, J.; Xu, L.; Gong, Z.; Chen, L. USP7-mediated deubiquitination of the KEAP1-NRF2-HMOX1 axis enhances radioresistance in non-small cell lung cancer by suppressing ferroptosis. Oncogene 45, 2196-210 (2026).
50. Li, Y. et al. Iron regulatory protein 2 is required for artemether -mediated anti-hepatic fibrosis through ferroptosis pathway. Free Radic. Biol. Med. 160, 845-59 (2020).
51. Zhang, T. et al. ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1. Nat. Cancer 3, 75-89 (2021).
52. Yao, F. et al. Iron regulatory protein 1 promotes ferroptosis by sustaining cellular iron homeostasis in melanoma. Oncol. Lett. 22, 657 (2021).
53. Chen, X.; Yu, C.; Kang, R.; Tang, D. Iron metabolism in ferroptosis. Front. Cell Dev. Biol. 8, 590226 (2020).
54. Ru, Q.; Li, Y.; Chen, L.; Wu, Y.; Min, J.; Wang, F. Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects. Sig. Transduct. Target. Ther. 9, 271 (2024).
55. Xing, P. et al. MTCH2 deficiency promotes E2F4/TFRC‐mediated ferroptosis and sensitizes colorectal cancer liver metastasis to sorafenib. Adv. Sci. 12, e00019 (2025).
56. Ma, T. et al. HPGD induces ferroptosis and autophagy to suppress esophageal squamous cell carcinoma through the LXA4-ERK1/2-U2AF2-TFRC axis. Mol. Cancer 24, 241 (2025).
57. Ge, Z. et al. Stress granules restrain ferroptosis by sequestering ferritin. Nat. Cell Biol. 28, 1204-18 (2026).
58. Sheng, S. et al. A ferritin-targeted biohybrid triggering ferroptosis immunotherapy via activating endogenous iron and replenishing exogenous iron simultaneously. Nat. Commun. 16, 6045 (2025).
59. Yang, X. et al. Ferritin light chain deficiency-induced ferroptosis is involved in preeclampsia pathophysiology by disturbing uterine spiral artery remodelling. Redox Biol. 58, 102555 (2022).
60. Kim, J.; Jo, Y.; Cho, D.; Ryu, D. L-threonine promotes healthspan by expediting ferritin-dependent ferroptosis inhibition in C. elegans. Nat. Commun. 13, 6554 (2022).
61. Hou, W. et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy 12, 1425-8 (2016).
62. Lu, Y. et al. MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma. Cell Death Dis. 12, 511 (2021).
63. Yi, L. et al. TFRC upregulation promotes ferroptosis in CVB3 infection via nucleus recruitment of Sp1. Cell Death Dis. 13, 592 (2022).
64. Song, W.; Shen, Q.; Zhang, H.; Bu, X.; Gao, W.; Wang, W. c‐MAF transcriptionally activates Slc40a1 to repress ferroptosis in sepsis-associated encephalopathy. CNS Neurosci. Ther. 32, e70820 (2026).
65. Li, K.; Yu, Z.; Zhou, Z.; Wu, Y.; Zhao, Y.; Zhang, E. Luteolin triggers autophagy-dependent ferroptosis via suppressing SLC40A1-related Fe2+ efflux in hepatocellular carcinoma (HCC). Eur. J. Pharmacol. 1021, 178809 (2026).
66. Zhang, Y. et al. Epigenetic suppression of Nrf2-Slc40a1 axis induces ferroptosis and enhances immunotherapy in pancreatic cancer. J. Immunother. Cancer 13, e013269 (2025).
67. Hao, L. et al. SLC40A1 mediates ferroptosis and cognitive dysfunction in type 1 diabetes. Neuroscience 463, 216-26 (2021).
68. Yu, Y. et al. Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis. Blood 136, 726-39 (2020).
69. Bucarey, J. L.; Casas, M.; Espinosa, A. Mitochondrial iron handling and lipid peroxidation as drivers of ferroptosis. Int. J. Mol. Sci. 27, 2232 (2026).
70. Song, Y. et al. Mitochondrial ferritin alleviates ferroptosis in a kainic acid-induced mouse epilepsy model by regulating iron homeostasis: involvement of nuclear factor erythroid 2‐related factor 2. CNS Neurosci. Ther. 30, e14663 (2024).
71. Zhu, L. et al. Programmed enhancement of endogenous iron-mediated lysosomal membrane permeabilization for tumor ferroptosis/pyroptosis dual-induction. Nat. Commun. 16, 3017 (2025).
72. Cañeque, T. et al. Activation of lysosomal iron triggers ferroptosis in cancer. Nature 642, 492-500 (2025).
73. Cen, S. Y. et al. Crizotinib and its enantiomer suppress ferroptosis by decreasing PE-O-PUFA content. Cell Death Discov. 10, 360 (2024).
74. Ma, X. H. et al. ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage. Signal Transduct. Target. Ther. 7, 288 (2022).
75. Nassar, Z. D. et al. Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis. ELife 9, e54166 (2020).
76. Yuan, H.; Li, X.; Zhang, X.; Kang, R.; Tang, D. Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem. Biophys. Res. Commun. 478, 1338-43 (2016).
77. Doll, S. et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 13, 91-8 (2017).
78. Kagan, V. E. et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat. Chem. Biol. 13, 81-90 (2017).
79. Yan, B. et al. Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol. Cell 81, 355-69.e10 (2021).
80. Magtanong, L. et al. Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state. Cell Chem. Biol. 26, 420-32.e9 (2019).
81. Luis, G. et al. Tumor resistance to ferroptosis driven by stearoyl-CoA desaturase-1 (SCD1) in cancer cells and fatty acid biding protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Redox Biol. 43, 102006 (2021).
82. Li, Z. et al. LPCAT1-mediated membrane phospholipid remodelling promotes ferroptosis evasion and tumour growth. Nat. Cell Biol. 26, 811-24 (2024).
83. Wang, N. et al. Lipid metabolism drives dietary effects on T cell ferroptosis and immunity. Nature 653, 200-11 (2026).
84. Qiu, B. et al. Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis. Cell 187, 1177-90.e18 (2024).
85. Morgan, P. K. et al. A lipid atlas of human and mouse immune cells provides insights into ferroptosis susceptibility. Nat. Cell Biol. 26, 645-59 (2024).
86. Zou, Y. et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature 585, 603-8 (2020).
87. Cui, W.; Liu, D.; Gu, W.; Chu, B. Peroxisome-driven ether-linked phospholipids biosynthesis is essential for ferroptosis. Cell Death Differ. 28, 2536-51 (2021).
88. Peng, X. et al. Peroxisome-derived and liver-specific hydroxyacid oxidase 1-mediated hydrogen peroxide promotes ferroptosis by augmenting peroxisomal ROS. J. Adv. Res. S2090-1232(26)00342-5 (2026).
89. Du, Y.; Shen, Y.; Wang, R.; Ren, X.; Ye, S. Role of lipid droplet-mediated lipid peroxidation by GPX4 in docosahexaenoic acid-induced EA.hy926 endothelial cell ferroptosis. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1871, 159748 (2026).
90. Motamedi, S. et al. AMP-activated protein kinase-driven lipid droplet dynamics govern melanoma sensitivity to polyunsaturated fatty acid and iron-induced ferroptosis. Nat. Commun. 16, 11252 (2025).
91. Lange, M. et al. FSP1-mediated lipid droplet quality control prevents neutral lipid peroxidation and ferroptosis. Nat Cell Biol. 27, 1902-13 (2025).
92. Klasson, T. D. et al. ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma. Cancer Metab. 10, 14 (2022).
94. Gao, M. ; Monian, P.; Quadri, N.; Ramasamy, R.; Jiang, X. Glutaminolysis and transferrin regulate ferroptosis. Mol. Cell 59, 298-308 (2015).
95. Liang, F. G. et al. OPA1 promotes ferroptosis by augmenting mitochondrial ROS and suppressing an integrated stress response. Mol. Cell 84, 3098-114.e6 (2024).
96. Li, C.; Liu, J.; Hou, W.; Kang, R.; Tang, D. STING1 promotes ferroptosis through MFN1/2-dependent mitochondrial fusion. Front. Cell Dev. Biol. 9, 698679 (2021).
97. Guo, W. et al. Mitochondrial CCN1 drives ferroptosis via fatty acid β-oxidation. Dev. Cell 60, 2294-312.e11 (2025).
98. Liu, X. et al. Endocytosis is essential for cysteine-deprivation-induced ferroptosis. Mol. Cell 85, 3333-42.e4 (2025).
99. Gao, H. et al. Ferroptosis is a lysosomal cell death process. Biochem. Biophys. Res. Commun. 503, 1550-6 (2018).
100. Gao, M.; Monian, P.; Pan, Q.; Zhang, W.; Xiang, J.; Jiang, X. Ferroptosis is an autophagic cell death process. Cell Res. 26, 1021-32 (2016).
101. Lu, J.; Tao, Y.; Li, J.; Wubuliaila, M.; Wang, J.; Li, N. TP53 links mitochondria-endoplasmic reticulum crosstalk and ferroptosis in septic cardiomyopathy: protective modulation by nicorandil. Cell. Signal. 144, 112537 (2026).
102. Dixon, S. J. et al. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. ELife 3, e02523 (2014).
103. von Krusenstiern, A. N. et al. Identification of essential sites of lipid peroxidation in ferroptosis. Nat. Chem. Biol. 19, 719-30 (2023).
104. Jacquemyn, J.; Cascalho, A.; Goodchild, R. E. The ins and outs of endoplasmic reticulum‐controlled lipid biosynthesis. EMBO Rep. 18, 1905-21 (2017).
105. Chang, J.; Wang, Y.; Kong, X.; Dong, B.; Yue, T. Golgi apparatus-targeting fluorescent probe for the imaging of superoxide anion (O2•-) in living cells during ferroptosis. Anal. Chim. Acta 1298, 342410 (2024).
106. Li, J. et al. TMEM87A suppresses ferroptosis and increases cancer immunotherapy resistance by maintaining the Golgi apparatus pH homeostasis. Nat. Cancer 7, 823-39 (2026).
107. Jiang, T.; Ma, W.; Dong, W.; Zhou, H.; Mao, X. Ferroptosis-associated transcriptional factors in neurological diseases: molecular mechanisms and therapeutic prospects. Exp. Mol. Med. 57, 2763-81 (2025).
108. Alim, I. et al. Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. Cell 177, 1262-79.e25 (2019).
109. Ramos, S.; Hartenian, E.; Santos, J. C.; Walch, P.; Broz, P. NINJ1 induces plasma membrane rupture and release of damage-associated molecular pattern molecules during ferroptosis. EMBO J. 43, 1164-86 (2024).
110. Riegman, M. et al. Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture. Nat. Cell Biol. 22, 1042-8 (2020).
111. Wen, Q.; Liu, J.; Kang, R.; Zhou, B.; Tang, D. The release and activity of HMGB1 in ferroptosis. Biochem. Biophys. Res. Commun. 510, 278-83 (2019).
112. Wiernicki, B. et al. Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity. Nat. Commun. 13, 3676 (2022).
113. Dai, E.; Meng, L.; Kang, R.; Wang, X.; Tang, D. ESCRT-III-dependent membrane repair blocks ferroptosis. Biochem. Biophys. Res. Commun. 522, 415-21 (2020).
114. Pedrera, L. et al. Ferroptotic pores induce Ca2+ fluxes and ESCRT-III activation to modulate cell death kinetics. Cell Death Differ. 28, 1644-57 (2021).
115. Galluzzi, L. et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 25, 486-541 (2018).
116. Friedmann Angeli, J. P. et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180-91 (2014).
117. Ma, Z. et al. Deferoxamine mitigates neuronal loss following spinal cord injury via ferroptosis inhibition and Nrf2/HO-1 pathway activation. Int. J. Mol. Med. 57, 137 (2026).
118. Liu, G. et al. Deferoxamine attenuates early brain injury after subarachnoid hemorrhage by inhibiting ferroptosis and preserving mitochondrial function and oxidative phosphorylation via Nrf2 signaling. J. Stroke Cerebrovasc. Dis. 35, 108644 (2026).
119. An, X.; Yu, W.; Liu, J.; Tang, D.; Yang, L.; Chen, X. Oxidative cell death in cancer: mechanisms and therapeutic opportunities. Cell Death Dis. 15, 556 (2024).
120. Tan, S., Schubert, D., Maher, P. Oxytosis: a novel form of programmed cell death. Curr. Top. Med. Chem. 1, 497-506 (2001).
121. van den Pol, A. N.; Wuarin, J. P.; Dudek, F. E. Glutamate, the dominant excitatory transmitter in neuroendocrine regulation. Science 250, 1276-8 (1990).
122. Sanchez, K. L. et al. Evidence of oxytosis/ferroptosis in niemann-pick disease type C. Int. J. Mol. Sci. 26, 2915 (2025).
124. Tang, D.; Honn, K. V. Apoptosis of W256 carcinosarcoma cells of the monocytoid origin induced by NDGA involves lipid peroxidation and depletion of GSH: Role of 12-lipoxygenase in regulating tumor cell survival. J. Cell. Physiol. 172, 155-70 (1997).
125. Groc, L. et al. Lipid peroxidation-mediated oxidative stress and dopamine neuronal apoptosis in the substantia nigra during development. Neurochem. Int. 39, 127-33 (2001).
126. Strassburger, M. et al. Heterozygous deficiency of manganese superoxide dismutase results in severe lipid peroxidation and spontaneous apoptosis in murine myocardium in vivo. Free Radic. Biol. Med. 38, 1458-70 (2005).
127. Liu, P. et al. The effects of selenium on GPX4‐mediated lipid peroxidation and apoptosis in germ cells. J. Appl. Toxicol. 42, 1016-28 (2021).
128. Madi, A. et al. DGAT1 mediates sex-specific CD8+ T cell antitumour responses. Nat. Metab. 8, 685-703 (2026).
129. Chen, L. et al. GL-V9 inhibits Caspase-11 activation‐induced pyroptosis by suppressing ALOX12‐mediated lipid peroxidation to alleviate sepsis. Br. J. Pharmacol. 182, 3767-85 (2025).
130. Kang, R. et al. Lipid peroxidation drives gasdermin D-mediated pyroptosis in lethal polymicrobial sepsis. Cell Host Microbe 24, 97-108.e4 (2018).
131. Hou, T.; Tang, Y.; Wang, L.; Peng, L.; Ci, X. Dihydromyricetin alleviates lipid peroxidation-induced Pyroptosis by inhibiting xCT ubiquitination and degradation in experimental COPD model. Phytomedicine 144, 156929 (2025).
132. Hou, T. et al. Lipid peroxidation triggered by the degradation of xCT contributes to gasdermin D-mediated pyroptosis in COPD. Redox Biol. 77, 103388 (2024).
133. Canli, Ö. et al. Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors. Blood 127, 139-48 (2016).
134. Müller, T. et al. Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure. Cell. Mol. Life Sci. 74, 3631-45 (2017).
135. Lei, Y.; Zhou, J.; Xu, D.; Chai, S.; Xiong, N. Corilagin attenuates neuronal apoptosis and ferroptosis of parkinson’s disease through regulating the TLR4/Src/NOX2 signaling pathway. ACS Chem. Neurosci. 16, 968-80 (2025).
136. Zhao, H.; Mao, H. ERRFI1 exacerbates hepatic ischemia reperfusion injury by promoting hepatocyte apoptosis and ferroptosis in a GRB2-dependent manner. Mol. Med. 30, 82 (2024).
137. Das, J. et al. Ferroptosis induces heterogeneous death profiles that are controlled by lysosome rupture. Dev. Cell 61, 760-72.e4 (2026).
138. Chen, R.; Zou, J.; Liu, J.; Kang, R.; Tang, D. DAMPs in the immunogenicity of cell death. Mol. Cell 85, 3874-89 (2025).
139. Broz, P.; Pelegrín, P.; Shao, F. The gasdermins, a protein family executing cell death and inflammation. Nat. Rev. Immunol. 20, 143-57 (2020).
140. Lee, J. Y. et al. Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer. Proc. Natl. Acad. Sci. U S A. 117, 32433-42 (2020).
142. Freitas, F. P. et al. 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis. Nature 626, 401-10 (2024).
143. Yamada, N. et al. Inhibition of 7-dehydrocholesterol reductase prevents hepatic ferroptosis under an active state of sterol synthesis. Nat. Commun. 15, 2195 (2024).
144. Liang, D. et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell 186, 2748-2764.e22 (2023).
145. Hirata, Y.; Mishima, E. Membrane Dynamics and cation handling in ferroptosis. Physiology 39, 73-87 (2024).
146. Lin, Z. et al. The lipid flippase SLC47A1 blocks metabolic vulnerability to ferroptosis. Nat. Commun. 13, 7965 (2022).
147. Yang, B. et al. Activation of GSDME by all-trans-retinal increases sensitivity to photoreceptor ferroptosis. Int. J. Biol. Sci. 21, 7029-42 (2025).
148. Song, X. et al. Cytosolic cytochrome c represses ferroptosis. Cell Metab. 37, 1326-43.e10 (2025).
149. Rizzollo, F. et al. BDH2-driven lysosome-to-mitochondria iron transfer shapes ferroptosis vulnerability of the melanoma cell states. Nat. Metab. 7, 1851-70 (2025).
150. Medina, A.; Banaszczak, M.; Ni, Y.; Aretz, I.; Meierhofer, D. ρ⁰ Cells feature de-ubiquitination of SLC transporters and increased levels and fluxes of amino acids. Int. J. Mol. Sci. 18, 879 (2017).
151. Yang, W. S.; Stockwell, B. R. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem. Biol. 15, 234-45 (2008).
152. Chen, X. Decoding GPX4 regulation in ferroptosis: mechanisms and therapeutic implications. Trends Mol. Med. S1471-4914(26)00012-2 (2026).
153. Matsushita, M.; Freigang, S.; Schneider, C.; Conrad, M.; Bornkamm, G. W.; Kopf, M. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J. Exp. Med. 212, 555-68 (2015).
154. Yant, L. J. et al. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radic. Biol. Med. 34, 496-502 (2003).
155. Palma, M. et al. Lymph node environment drives FSP1 targetability in metastasizing melanoma. Nature 649, 477-86 (2026).
157. Chen, X. et al. A noncanonical function of EIF4E limits ALDH1B1 activity and increases susceptibility to ferroptosis. Nat. Commun. 13, 6318 (2022).
158. Miriyala, S. et al. Novel role of 4-hydroxy-2-nonenal in AIFm2-mediated mitochondrial stress signaling. Free Radic. Biol. Med. 91, 68-80 (2016).
159. Xia, Z. et al. A GPX1-OSBPL8 axis mediates noncanonical in vivo ferroptosis and cancer growth suppression. Cell 189, 1957-74.e17 (2026).
160. Sousa, J. A. et al. GPx1 deficiency confers increased susceptibility to ferroptosis in macrophages from individuals with active Crohn’s disease. Cell Death Dis. 15, 903 (2024).
161. Zhou, Y. et al. GPX7 is targeted by miR-29b and GPX7 knockdown enhances ferroptosis induced by erastin in glioma. Front. Oncol. 11, 802124 (2022).
162. Chen, B. et al. GPX7 reduces chondrocyte inflammation and extracellular matrix degradation triggered by IL-1β, via a mechanism mediated by ferroptosis. Mol. Med. Rep. 30, 118 (2024).
163. Li, X. N. et al. Blue honeysuckle (Lonicera caerulea L.)-anthocyanins and cyanidin-3-O-glucoside protect dopaminergic neurons against ferroptosis by activating the Nrf2-GPX7 axis. Free Radic. Biol. Med. 239, 242-56 (2025).
164. Dai, E. et al. Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173/STING-dependent DNA sensor pathway. Nat. Commun. 11, 6339 (2020).
166. Li, M. et al. Spermine is an endogenous iron chelator that inhibits ferroptosis. Nature 655, 240-50 (2026).
167. Wenzel, S. E. et al. PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals. Cell 171, 628-41.e26 (2017).
168. Zielinski, Z. A. M.; Pratt, D. A. Lipid peroxidation: kinetics, mechanisms, and products. J. Org. Chem. 82, 2817-25 (2017).
169. Suda, A. et al. Polyunsaturated fatty acids-induced ferroptosis suppresses pancreatic cancer growth. Sci. Rep. 14, 4409 (2024).
170. Liang, Y. et al. Advanced alcoholic liver disease driven by a proferroptotic diet. J. Lipid Res. 66, 100898 (2025).
171. Mayr, L. et al. Dietary lipids fuel GPX4-restricted enteritis resembling Crohn’s disease. Nat. Commun. 11, 1775 (2020).
172. Awasthi, D. et al. Dietary polyunsaturated fatty acids regulate dendritic cell function via Nrf2-dependent control of ferroptosis. Research Square (2025) Epub ahead of print.
173. Costa, E. A.; Gonçalves, A. P.; Batista, J. A. D.; Bazoni, R. F.; Santos, A. A.; Rocha, M. S. new insights into the mechanism of action of the drug chloroquine: direct interaction with DNA and cytotoxicity. J. Phys. Chem. B. 126, 3512-21 (2022).
174. Chen, X. et al. International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis. Autophagy 20, 1213-46 (2024).
175. Woo, M. S. et al. STING orchestrates the neuronal inflammatory stress response in multiple sclerosis. Cell 187, 4043-60.e30 (2024).
176. Dong, W. et al. Restoring cardiolipin homeostasis mitigates cerebral ischemia-reperfusion injury by suppressing ATG5-mediated neuronal autophagy-dependent ferroptosis. J. Adv. Res. S2090-1232(26)00234-1 (2026).
177. Luo, C. et al. Autophagy induced by mechanical stress sensitizes cells to ferroptosis by NCOA4-FTH1 axis. Autophagy 21, 1263-82 (2025).
178. Wu, Z. et al. UCHL1 alleviates nucleus pulposus cell senescence by promoting chaperone-mediated autophagy antagonizing autophagy-dependent ferroptosis through deubiquitination of HSPA8. Autophagy 21, 2842-66 (2025).
179. Yang, L.; Ye, F.; Liu, J.; Klionsky, D. J.; Tang, D.; Kang, R. Extracellular SQSTM1 exacerbates acute pancreatitis by activating autophagy-dependent ferroptosis. Autophagy 19, 1733-44 (2023).
180. Chen, J. et al. P23 acts as a negative regulator of ferroptosis in NSCLC by blocking GPX4 degradation via chaperone-mediated autophagy. Mol. Cancer 24, 234 (2025).
181. Chen, X. Lysosome: a critical hub for ferroptosis regulation. Trends Cell Biol. 36, 561-77 (2026).
182. Chen, X. et al. Identification of HPCAL1 as a specific autophagy receptor involved in ferroptosis. Autophagy 19, 54-74 (2023).
183. Liu, J. et al. TMEM164 is a new determinant of autophagy-dependent ferroptosis. Autophagy 19, 945-56 (2023).
184. Yang, M. et al. Clockophagy is a novel selective autophagy process favoring ferroptosis. Sci. Adv. 5, eaaw2238 (2019).
185. Mun, S. H. et al. Marchf6 E3 ubiquitin ligase critically regulates endoplasmic reticulum stress, ferroptosis, and metabolic homeostasis in POMC neurons. Cell Rep. 42, 112746 (2023).
186. Ma, Y. et al. Paris polyphylla saponin Ⅱ induces autophagy-associated ferroptosis by regulating the BECLIN1/SLC7A11 axis in cervical cancer. Eur. J. Pharmacol. 1027, 178969 (2026).
187. Lian, D.; Zhang, Q.; Li, H. Knockdown of PTEN inhibits autophagy-dependent ferroptosis to alleviate LPS-induced sepsis-associated acute kidney injury. Inflammation (2026) Epub ahead of print.
188. Huang, W. et al. Stabilizing MARCH7 as a ferro-guardian against ferroptosis. Cell 189, 3553-70.e30 (2026).
189. Bai, Y. et al. Lipid storage and lipophagy regulates ferroptosis. Biochem. Biophys. Res. Commun. 508, 997-1003 (2019).
190. Zhao, Y. et al. Chronic intermittent cold stress-induced lipophagy promotes foamy macrophage susceptibility to ferroptosis and exacerbates atherosclerosis. Free Radic. Biol. Med. 242, 636-53 (2026).
191. Zhang, Y. et al. LAPTM5-dependent lipophagy enhances ferroptosis sensitivity in glioma cells. Transl. Cancer Res. 15, 171 (2026).
192. Hubbi, M. E. et al. The HIF-2 transcription factor mediates resistance to ferroptosis in pancreatic cancer. Mol. Cell 86, 1260-74.e4 (2026).
193. Zhao, D. et al. Roxadustat ameliorates thoracic aortic dissection by activating HIF‐1α‐mediated mitophagy to inhibit ferroptosis. FASEB J. 40, e71979 (2026).
194. Liu, S. et al. Scutellarein attenuates intervertebral disc degeneration by promoting PINK1/parkin‐mediated mitophagy to alleviate inflammation, ferroptosis, and mitochondrial dysfunction in nucleus pulposus cells. Phytother. Res. 40, 2986-3008 (2026).
195. Zhong, L. et al. Cardiomyocyte-derived GPX4 stabilizes BNIP3 to facilitate mitophagy and mitigate myocardial ischemia/reperfusion injury. Nat. Commun. 17, 4578 (2026).
196. Yagoda, N. et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447, 864-8 (2007).
197. Cheff, D. M. et al. The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1. Redox Biol. 62, 102703 (2023).
198. Herrick, W. G. et al. Potent ferroptosis agent RSL3 induces cleavage of Pyroptosis-Specific gasdermins in Cancer cells. Sci. Rep. 15, 25249 (2025).
199. Ding, Z. et al. URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers. Nat. Commun. 14, 6269 (2023).
200. Liu, L. et al. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res. 66, 11851-8 (2006).
201. Chen, Y. L. et al. Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes. Hepatology 53, 1708-18 (2011).
202. Liptay, S. et al. Molecular mechanisms of sulfasalazine‐induced T-cell apoptosis. Br. J. Pharmacol. 137, 608-20 (2009).
203. Moniruzzaman, R. et al. Roles of intracellular and extracellular ROS formation in apoptosis induced by cold atmospheric helium plasma and X-irradiation in the presence of sulfasalazine. Free Radic. Biol. Med. 129, 537-47 (2018).
204. Shimada, K. et al. Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat. Chem. Biol. 12, 497-503 (2016).
205. Gaschler, M. M. et al. FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation. Nat. Chem. Biol. 14, 507-15 (2018).
206. Huang, W. et al. Liproxstatin-1 attenuates retinal ischemia-reperfusion injury by suppressing EGR1-mediated ferroptosis. Antioxidants 15, 391 (2026).
207. Luo, Y.; Han, J.; Huang, G. NUPR1 alleviates renal ischemia reperfusion injury by inhibiting ferroptosis involving the ATF4-CHAC1 pathway. Cell. Signal. 144, 112547 (2026).
208. Wu, T. et al. STING1 exacerbates iodinated contrast-induced acute kidney injury by promoting ferroptosis through chaperone-mediated autophagic degradation of FTH1. Autophagy 22, 1081-96 (2026).
209. Yang, Y. et al. The nuclear receptor ESRRA is a crucial regulator of acute kidney injury through inhibition of the lipophagy-ferroptosis axis. Autophagy 22, 1903-24 (2026).
210. Qiao, Z. et al. IFI16 is essential to linking DNA damage and ferroptosis in acute kidney injury. Cell Death Dis. 17, 350 (2026).
211. Balasubramaniam, A. et al. Western diet induces iron-dependent enteric neurodegeneration via ferroptosis. J. Clin. Investig. 136, e196113 (2026).
212. Taha, M.; Salah, D.; Abdou, K.; Senousy, M. A. Roflumilast elicits therapeutic and neuroprotective effects in 3-nitropropionic acid-induced Huntington’s disease-like neurodegeneration in rats by mitigating NLRP3 inflammasome-mediated pyroptosis, ferroptosis, and glial activation. Neurochem. Res. 51, 92 (2026).
213. Feng, H. et al. Transferrin receptor is a specific ferroptosis marker. Cell Rep. 30, 3411-23.e7 (2020).
214. Cui, S. et al. Identification of hyperoxidized PRDX3 as a ferroptosis marker reveals ferroptotic damage in chronic liver diseases. Mol. Cell 83, 3931-9.e5 (2023).
215. Efimova, I. et al. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J. Immunother. Cancer 8, e001369 (2020).
216. Liu, J. et al. DCN released from ferroptotic cells ignites AGER-dependent immune responses. Autophagy 18, 2036-49 (2022).
217. Liu, J. et al. Extracellular GPX4 impairs antitumor immunity via dendritic ZP3 receptors. Cell 189, 1056-73.e24 (2026).
218. Viswanathan, V. S. et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature 547, 453-7 (2017).
219. Tonnus, W. et al. Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury. Nat. Commun. 12, 4402 (2021).
220. Tonnus, W. et al. Multiple oestradiol functions inhibit ferroptosis and acute kidney injury. Nature 645, 1011-9 (2025).
221. Ralhan, I. et al. Autolysosomal exocytosis of lipids protect neurons from ferroptosis. J. Cell Biol. 222, e202207130 (2023).
222. Tian, R. et al. Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis. Nat. Neurosci. 24, 1020-34 (2021).
223. Levi, S.; Ripamonti, M.; Moro, A. S.; Cozzi, A. Iron imbalance in neurodegeneration. Mol. Psychiatry 29, 1139-52 (2024).
224. Zheng, Y.; Sun, J.; Luo, Z.; Li, Y.; Huang, Y. Emerging mechanisms of lipid peroxidation in regulated cell death and its physiological implications. Cell Death Dis. 15, 859 (2024).
225. Kang, R.; Liu, J.; Wang, J.; Kroemer, G.; Tang, D. Translating ferroptosis into oncology: challenges, opportunities and future directions. Nat. Rev. Clin. Oncol. 23, 401-24 (2026).
226. Wientjens, C. et al. Tolerance to ferroptosis facilitates lipid metabolism and pathogenic type 2 immunity in allergic airway inflammation. Immunity 59, 322-38.e9 (2026).
227. Garg, A. et al. Vitamin B2 and B3 nutrigenomics reveals a therapy for NAXD disease. Cell 189, 2648-62.e19 (2026).
228. Shi, L. et al. The DRD2 antagonist haloperidol mediates autophagy-induced ferroptosis to increase temozolomide sensitivity by promoting endoplasmic reticulum stress in glioblastoma. Clin. Cancer Res. 29, 3172-88 (2023).
229. Cramer, S. L. et al. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth. Nat. Med. 23, 120-7 (2016).
230. Badgley, M. A. et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science 368, 85-9 (2020).
231. Veeckmans, G. et al. Ferroptosis inhibition enhances liver and lung graft function. Cell 189, 3991-4004.e26 (2026).
232. Liu, K. et al. Trypsin-mediated sensitization to ferroptosis increases the severity of pancreatitis in mice. Cell Mol. Gastroenterol Hepatol. 13, 483-500 (2022).
233. Lorenz, S. M. et al. A fin-loop-like structure in GPX4 underlies neuroprotection from ferroptosis. Cell 189, 287-306.e35 (2026).
234. Liu, H. et al. Characterization of a patient-derived variant of GPX4 for precision therapy. Nat. Chem. Biol. 18, 91-100 (2022).
235. Ma, X. et al. CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability. Cell Metab. 33, 1001-12.e5 (2021).
236. Ferrer, M. et al. Ketogenic diet promotes tumor ferroptosis but induces relative corticosterone deficiency that accelerates cachexia. Cell Metab. 35, 1147-62.e7 (2023).
237. Li, J. et al. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci. Transl. Med. 15, eadg3049 (2023).
238. Dolga, A. M. et al. Mitochondrial Small Conductance SK2 channels prevent glutamate-induced oxytosis and mitochondrial dysfunction. J. Biol. Chem. 288, 10792-804 (2013).
239. Cheng, B. et al. Induction of ferroptosis in prostate cancer by CCDC719-13 via TRIM21-mediated ubiquitination of SLC7A11. Cell Death Differ. 33, 605-25 (2026).
240. Chen, Q. et al. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma. Cell Death Differ. 30, 137-51 (2023).
241. Sen, U. et al. SCD1 inhibition blocks the AKT-NRF2-SLC7A11 pathway to induce lipid metabolism remodeling and ferroptosis priming in lung adenocarcinoma. Cancer Res. 85, 2485-503 (2025).
242. Liu, T.; Jiang, L.; Tavana, O.; Gu, W. The deubiquitylase OTUB1 mediates ferroptosis via stabilization of SLC7A11. Cancer Res. 79, 1913-24 (2019).
243. Li, Z. et al. Tumor-repopulating cells evade ferroptosis via PCK2-dependent phospholipid remodeling. Nat. Chem. Biol. 20, 1341-52 (2024).
244. Schwab, A. et al. Zeb1 mediates EMT/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition. Nat. Cell Biol. 26, 1470-81 (2024).
245. Kim, J. W. et al. Methionine metabolism is linked with phospholipid and glutamine metabolism to drive ferroptosis. Cell Rep. 45, 117157 (2026).
246. Ruiz, C. F. et al. Diet-induced phospholipid remodeling dictates ferroptosis sensitivity and tumorigenesis in the pancreas. Cancer Discov. (2026) Epub ahead of print.
247. Reed, A. et al. LPCAT3 inhibitors remodel the polyunsaturated phospholipid content of human cells and protect from ferroptosis. ACS Chem. Biol. 17, 1607-18 (2022).
248. Tai, P. et al. WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis. J. Transl. Med. 21, 823 (2023).
249. Pan, Y. et al. STX17-DT facilitates axitinib resistance in renal cell carcinoma by inhibiting mitochondrial ROS accumulation and ferroptosis. Cell Death Dis. 16, 125 (2025).
250. Jang, S. K. et al. Inhibition of VDAC1 oligomerization blocks cysteine deprivation-induced ferroptosis via mitochondrial ROS suppression. Cell Death Dis. 15, 811 (2024).
251. Yao, Y. et al. Selenium-GPX4 axis protects follicular helper T cells from ferroptosis. Nat. Immunol. 22, 1127-39 (2021).
252. Eaton, J. K. et al. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles. Nat. Chem. Biol. 16, 497-506 (2020).
253. Wu, K. et al. Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting function. Nat. Cell Biol. 25, 714-25 (2023).
254. Zhou, L. et al. Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity. Nat. Cancer 6, 768-85 (2025).
255. Brown, C. W. et al. Prominin2 drives ferroptosis resistance by stimulating iron export. Dev. Cell 51, 575-86.e4 (2019).
256. Zhou, H. et al. NCOA4-mediated ferritinophagy is involved in ionizing radiation-induced ferroptosis of intestinal epithelial cells. Redox Biol. 55, 102413 (2022).
257. Liu, L. et al. Suppression of USP8 sensitizes cells to ferroptosis via SQSTM1/p62-mediated ferritinophagy. Protein Cell 14, 230-4 (2023).
258. Yu, F. et al. Dynamic O-GlcNAcylation coordinates ferritinophagy and mitophagy to activate ferroptosis. Cell Discov. 8, 40 (2022).
259. Koshizuka, K. et al. Genome-wide CRISPR screening reveals that mTOR inhibition initiates ferritinophagy and ferroptosis in head and neck cancer. Cancer Res. 85, 3032-51 (2025).
260. Wu, H.; Liu, Q.; Shan, X.; Gao, W.; Chen, Q. ATM orchestrates ferritinophagy and ferroptosis by phosphorylating NCOA4. Autophagy 19, 2062-77 (2023).
261. Qin, X. et al. Ferritinophagy is involved in the zinc oxide nanoparticles-induced ferroptosis of vascular endothelial cells. Autophagy 17, 4266-85 (2021).
262. Zhang, T. et al. POLR1A inhibits ferroptosis by regulating TFAM-mediated mitophagy and iron homeostasis. Redox Biol. 85, 103758 (2025).
263. Shen, J. et al. Nlrp6 protects from corticosterone-induced NSPC ferroptosis by modulating RIG-1/MAVS-mediated mitophagy. Redox Biol. 73, 103196 (2024).
264. Tang, R. et al. Narciclasine mitigates sepsis-induced cardiac dysfunction by enhancing BNIP3-mediated mitophagy and suppressing ferroptosis. Free Radic. Biol. Med. 238, 220-34 (2025).
265. Han, Z. et al. Acteoside alleviates lipid peroxidation by enhancing Nrf2-mediated mitophagy to inhibit ferroptosis for neuroprotection in Parkinson’s disease. Free Radic. Biol. Med. 223, 493-505 (2024).
266. Liu, W.; Wu, G.; Wang, J.; Wu, S.; Chen, Z. Co-treatment with triptolide and RSL3 induces hepatocellular carcinoma cell apoptosis and ferroptosis. Mol. Med. Rep. 32, 202 (2025).
267. Liu, L. et al. RSL3 enhances ROS-mediated cell apoptosis of myelodysplastic syndrome cells through MYB/Bcl-2 signaling pathway. Cell Death Dis. 15, 465 (2024).
268. Chen, L.; Chen, D.; Yang, F.; Chen, X.; Zheng, B. RSL3 promotes STAT3 ubiquitination to induce autophagy and apoptosis in PARPi-resistant breast cancer cells. Biomolecules 15, 1749 (2025).
269. Žarković, N. et al. Overview of the lipid peroxidation measurements in patients by the enzyme-linked immunosorbent assay specific for the 4-hydroxynonenal-protein adducts (4-HNE-ELISA). Front. Biosci. 29, 153 (2024).
270. Zaki, M. S. A. et al. The possible effects of α-tocopherol against amiodarone-treated lungs in rats: vimentin detection, lipid peroxidation assay, and histological and ultrastructural evaluations. Environ. Sci. Pollut. Res. 29, 58231-9 (2022).
271. Stockert, J. C. Lipid peroxidation assay using BODIPY-phenylbutadiene probes: a methodological overview. Methods Mol. Biol. 2202, 199-214 (2021).
272. Semerád, J. et al. Novel assay for the toxicity evaluation of nanoscale zero-valent iron and derived nanomaterials based on lipid peroxidation in bacterial species. Chemosphere 213, 568-77 (2018).
273. Lyu, Z. et al. Increased ZNF83 is a potential prognostic biomarker and regulates oxidative stress-induced ferroptosis in clear cell renal cell carcinoma. J. Mol. Med. 103, 583-97 (2025).
274. Chen, K. et al. Ferroptosis resistance-related TEP1 as a novel prognostic biomarker involved in immune cell infiltration and tumour progression in glioblastoma. Cancer Cell Int. 26, 14 (2025).
275. Cheng, B. et al. MT1G, an emerging ferroptosis‐related gene: a novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer. Environ. Toxicol. 39, 927-41 (2024).
276. Wen, J. et al. OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism. Front. Oncol. 12, 977348 (2022).
277. Xu, S. et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors. Immunity 54, 1561-77.e7 (2021).
